75,685 Shares in LENSAR, Inc. (NASDAQ:LNSR) Acquired by Huntleigh Advisors Inc.

Huntleigh Advisors Inc. bought a new position in shares of LENSAR, Inc. (NASDAQ:LNSR - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 75,685 shares of the company's stock, valued at approximately $1,069,000. Huntleigh Advisors Inc. owned 0.64% of LENSAR at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of the stock. Brandes Investment Partners LP lifted its position in shares of LENSAR by 10.4% during the 4th quarter. Brandes Investment Partners LP now owns 489,318 shares of the company's stock worth $4,375,000 after buying an additional 45,920 shares during the period. Renaissance Technologies LLC raised its position in LENSAR by 13.3% in the 4th quarter. Renaissance Technologies LLC now owns 348,891 shares of the company's stock valued at $3,119,000 after purchasing an additional 40,946 shares during the last quarter. Geode Capital Management LLC raised its position in LENSAR by 5.6% in the 4th quarter. Geode Capital Management LLC now owns 106,058 shares of the company's stock valued at $948,000 after purchasing an additional 5,627 shares during the last quarter. Essex Investment Management Co. LLC raised its position in LENSAR by 18.3% in the 4th quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company's stock valued at $357,000 after purchasing an additional 6,184 shares during the last quarter. Finally, Atria Investments Inc raised its position in LENSAR by 28.2% in the 4th quarter. Atria Investments Inc now owns 26,055 shares of the company's stock valued at $233,000 after purchasing an additional 5,729 shares during the last quarter. Institutional investors own 40.15% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have issued reports on LNSR shares. Lake Street Capital reiterated a "hold" rating and issued a $15.00 price objective (down previously from $16.00) on shares of LENSAR in a research report on Monday, March 24th. BTIG Research downgraded LENSAR from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 24th.

LENSAR Stock Performance

Shares of LNSR opened at $13.19 on Friday. The stock has a fifty day moving average price of $13.37 and a two-hundred day moving average price of $12.14. LENSAR, Inc. has a 52-week low of $3.50 and a 52-week high of $17.31. The company has a market cap of $155.50 million, a price-to-earnings ratio of -2.72 and a beta of 0.50.

LENSAR (NASDAQ:LNSR - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported ($2.32) earnings per share for the quarter, missing analysts' consensus estimates of ($0.16) by ($2.16). The firm had revenue of $11.53 million for the quarter, compared to the consensus estimate of $13.40 million. LENSAR had a negative return on equity of 737.30% and a negative net margin of 99.17%.

LENSAR Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

Want to see what other hedge funds are holding LNSR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LENSAR, Inc. (NASDAQ:LNSR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.